BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 7578394)

  • 1. Cancer gene therapy using plasmid DNA: purification of DNA for human clinical trials.
    Horn NA; Meek JA; Budahazi G; Marquet M
    Hum Gene Ther; 1995 May; 6(5):565-73. PubMed ID: 7578394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer gene therapy using plasmid DNA: safety evaluation in rodents and non-human primates.
    Parker SE; Vahlsing HL; Serfilippi LM; Franklin CL; Doh SG; Gromkowski SH; Lew D; Manthorpe M; Norman J
    Hum Gene Ther; 1995 May; 6(5):575-90. PubMed ID: 7578395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification of a cystic fibrosis plasmid vector for gene therapy using hydrophobic interaction chromatography.
    Diogo MM; Queiroz JA; Monteiro GA; Martins SA; Ferreira GN; Prazeres DM
    Biotechnol Bioeng; 2000 Jun; 68(5):576-83. PubMed ID: 10797245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Large-scale purification of pharmaceutical-grade plasmid DNA using tangential flow filtration and multi-step chromatography.
    Sun B; Yu X; Yin Y; Liu X; Wu Y; Chen Y; Zhang X; Jiang C; Kong W
    J Biosci Bioeng; 2013 Sep; 116(3):281-6. PubMed ID: 23660074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical pharmacokinetics, manufacturing, and safety studies supporting a multicenter cancer gene therapy trial.
    Norman JA; Parker S; Lew D; Manthorpe M; Marquet M
    Hum Gene Ther; 1995 May; 6(5):549-50. PubMed ID: 7578391
    [No Abstract]   [Full Text] [Related]  

  • 6. Production of plasmid DNA encoding human hepatocyte growth factor for gene therapy.
    Zhang Q; Bi J; Xiao F; Duan H; Wu B; Wu Z
    Biotechnol Appl Biochem; 2008 Jan; 49(Pt 1):11-6. PubMed ID: 17516916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of HLA-B7/beta-2 microglobulin plasmid DNA/lipid complex (Allovectin-7) in patients with metastatic melanoma.
    Bergen M; Chen R; Gonzalez R
    Expert Opin Biol Ther; 2003 Apr; 3(2):377-84. PubMed ID: 12662150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of clinical-grade plasmid DNA for human Phase I clinical trials and large animal clinical studies.
    Przybylowski M; Bartido S; Borquez-Ojeda O; Sadelain M; Rivière I
    Vaccine; 2007 Jun; 25(27):5013-24. PubMed ID: 17537555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer gene therapy using plasmid DNA: pharmacokinetic study of DNA following injection in mice.
    Lew D; Parker SE; Latimer T; Abai AM; Kuwahara-Rundell A; Doh SG; Yang ZY; Laface D; Gromkowski SH; Nabel GJ
    Hum Gene Ther; 1995 May; 6(5):553-64. PubMed ID: 7578393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue distribution of the cytofectin component of a plasmid-DNA/cationic lipid complex following intravenous administration in mice.
    Parker SE; Ducharme S; Norman J; Wheeler CJ
    Hum Gene Ther; 1997 Mar; 8(4):393-401. PubMed ID: 9054514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human gene therapy for melanoma: CT-guided interstitial injection.
    Waddill W; Wright W; Unger E; Stopeck A; Akporiaye E; Harris D; Grogan T; Schluter S; Hersh E; Stahl S
    AJR Am J Roentgenol; 1997 Jul; 169(1):63-7. PubMed ID: 9207502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of process flow sheets for the purification of supercoiled plasmids for gene therapy applications.
    Ferreira GN; Cabral JM; Prazeres DM
    Biotechnol Prog; 1999; 15(4):725-31. PubMed ID: 10441364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmid DNA purification.
    Stadler J; Lemmens R; Nyhammar T
    J Gene Med; 2004 Feb; 6 Suppl 1():S54-66. PubMed ID: 14978751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using a single hydrophobic-interaction chromatography to purify pharmaceutical-grade supercoiled plasmid DNA from other isoforms.
    Bo H; Wang J; Chen Q; Shen H; Wu F; Shao H; Huang S
    Pharm Biol; 2013 Jan; 51(1):42-8. PubMed ID: 23013372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large-scale, nonchromatographic purification of plasmid DNA.
    Murphy JC; Winters MA; Sagar SL
    Methods Mol Med; 2006; 127():351-62. PubMed ID: 16988465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Removal of contaminant nucleic acids by nitrocellulose filtration during pharmaceutical-grade plasmid DNA processing.
    Levy MS; Collins IJ; Tsai JT; Shamlou PA; Ward JM; Dunnill P
    J Biotechnol; 2000 Jan; 76(2-3):197-205. PubMed ID: 10656334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I study of direct gene transfer of an allogeneic histocompatibility antigen, HLA-B7, in patients with metastatic melanoma.
    Stopeck AT; Hersh EM; Akporiaye ET; Harris DT; Grogan T; Unger E; Warneke J; Schluter SF; Stahl S
    J Clin Oncol; 1997 Jan; 15(1):341-9. PubMed ID: 8996161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production, purification and analysis of an experimental DNA vaccine against rabies.
    Diogo MM; Ribeiro SC; Queiroz JA; Monteiro GA; Tordo N; Perrin P; Prazeres DM
    J Gene Med; 2001; 3(6):577-84. PubMed ID: 11778904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmid DNA production combining antibiotic-free selection, inducible high yield fermentation, and novel autolytic purification.
    Carnes AE; Hodgson CP; Luke JM; Vincent JM; Williams JA
    Biotechnol Bioeng; 2009 Oct; 104(3):505-15. PubMed ID: 19557837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A continuous cell alkaline lysis, neutralization, and clarification combination process for production of plasmid pUDK-HGF.
    Chunsheng H; Qinglin Z; Yuxin L; Xiaochen C; Yanliang W; Tong Z; Zuze W
    Biotechnol Appl Biochem; 2011 May; 58(3):162-5. PubMed ID: 21679239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.